Xanthoma is a skin condition characterized by the appearance of yellowish bumps or plaques on the skin. It is caused by an accumulation of cholesterol, lipids, and other fatty substances in the skin. While the exact cause of xanthoma is not known, it is believed to be associated with certain genetic disorders, high cholesterol levels, and certain medications. Xanthoma can occur at any age, but it is most common in adults between the ages of 40 and 60. The condition can be cosmetically disfiguring and can cause physical discomfort, as well as psychological distress. Treatment for xanthoma is focused on reducing cholesterol levels, controlling the underlying condition, and removing the lesions. In some cases, surgery may be necessary to remove the lesions. In this article, we will discuss the causes and treatments of xanthoma, and how these treatments can provide new hope for sufferers.
Xanthoma is caused by an accumulation of cholesterol, lipids, and other fatty substances in the skin. The exact cause of this accumulation is not known, but it is believed to be associated with certain genetic disorders, high cholesterol levels, and certain medications. Genetic disorders associated with xanthoma include familial hypercholesterolemia, which is an inherited condition that causes high levels of cholesterol in the blood. Other conditions such as diabetes, hypothyroidism, and kidney disease can also increase the risk of xanthoma. Certain medications, such as steroids, can also increase the risk of xanthoma. In addition, people who have been exposed to radiation or certain chemicals may be more likely to develop xanthoma.
Xanthoma typically appears as small yellowish bumps or plaques on the skin. The lesions may be firm or soft, and they may be itchy or painful. They may also appear on the eyelids, around the eyes, or on the elbows, knees, buttocks, and other areas of the body.
Xanthoma is typically diagnosed through a physical examination and a review of medical history. Blood tests may also be performed to check cholesterol levels. The goal of treatment is to reduce cholesterol levels and control the underlying condition. In some cases, surgery may be necessary to remove the lesions.
In addition to medical treatment, lifestyle changes can help manage xanthoma. These include: • Eating a healthy diet that is low in saturated fats and cholesterol • Exercising regularly • Quitting smoking • Limiting alcohol consumption • Reducing stress • Taking medications as prescribed
New treatments for xanthoma are being developed and tested. These include laser therapy, cryotherapy, and topical medications. Laser therapy uses a focused beam of light to reduce the appearance of xanthoma lesions. Cryotherapy involves freezing the lesions with liquid nitrogen. Topical medications can be applied directly to the lesions to reduce their size.
Xanthoma is a skin condition characterized by the appearance of yellowish bumps or plaques on the skin. While the exact cause of xanthoma is not known, it is believed to be associated with certain genetic disorders, high cholesterol levels, and certain medications. Treatment for xanthoma is focused on reducing cholesterol levels, controlling the underlying condition, and removing the lesions. In addition to medical treatment, lifestyle changes can help manage xanthoma. New treatments for xanthoma, such as laser therapy, cryotherapy, and topical medications, are being developed and tested. These treatments can provide new hope for sufferers of xanthoma.
1.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
2.
FDA approves Blenrep for relapsed or refractory multiple myeloma
3.
X-ray and radar technology combined to reduce cancer screening risks
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
The New Era of Oncology: Key Updates and Clinical Insights
4.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation